| High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation L Iovino, F Mazziotta, G Carulli, F Guerrini, R Morganti, V Mazzotti, ... Leukemia research 70, 20-24, 2018 | 58 | 2018 |
| Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma J Zurko, J Ramdial, M Shadman, S Ahmed, A Szabo, L Iovino, AA Tomas, ... Haematologica 108 (1), 98, 2023 | 54 | 2023 |
| Novel therapies in chronic lymphocytic leukemia: a rapidly changing landscape L Iovino, M Shadman Current Treatment Options in Oncology 21, 1-16, 2020 | 53 | 2020 |
| Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects R Giacconi, F Maggi, L Macera, M Pistello, M Provinciali, S Giannecchini, ... Experimental gerontology 112, 103-111, 2018 | 42 | 2018 |
| Dynamics of thymus function and T cell receptor repertoire breadth in health and disease D Granadier, L Iovino, S Kinsella, JA Dudakov Seminars in immunopathology 43, 119-134, 2021 | 37 | 2021 |
| The minimal residual disease in non-Hodgkin's lymphomas: from the laboratory to the clinical practice S Galimberti, E Genuardi, F Mazziotta, L Iovino, F Morabito, S Grassi, ... Frontiers in oncology 9, 528, 2019 | 37 | 2019 |
| The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia F Guerrini, M Paolicchi, F Ghio, E Ciabatti, S Grassi, S Salehzadeh, ... Frontiers in Pharmacology 7, 363, 2016 | 36 | 2016 |
| Panobinostat for the treatment of acute myelogenous leukemia F Morabito, MT Voso, S Hohaus, M Gentile, E Vigna, AG Recchia, L Iovino, ... Expert opinion on investigational drugs 25 (9), 1117-1131, 2016 | 31 | 2016 |
| The polycomb BMI1 protein is co-expressed with CD26+ in leukemic stem cells of chronic myeloid leukemia S Galimberti, S Grassi, C Baratè, F Guerrini, E Ciabatti, F Perutelli, F Ricci, ... Frontiers in Oncology 8, 555, 2018 | 19 | 2018 |
| Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy L Iovino, LA Thur, S Gnjatic, A Chapuis, F Milano, JA Hill Journal for Immunotherapy of Cancer 9 (5), 2021 | 16 | 2021 |
| Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice L Iovino, K Cooper, P Deroos, S Kinsella, C Evandy, T Ugrai, F Mazziotta, ... Blood, The Journal of the American Society of Hematology 139 (25), 3655-3666, 2022 | 14 | 2022 |
| The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia S Grassi, S Palumbo, V Mariotti, D Liberati, F Guerrini, E Ciabatti, ... Frontiers in Oncology 9, 532, 2019 | 14 | 2019 |
| CAR T-cell therapy for CLL: a new addition to our treatment toolbox L Iovino, M Shadman Clin Adv Hematol Oncol H&O 21, 134-41, 2023 | 8 | 2023 |
| Attenuation of apoptotic cell detection triggers thymic regeneration after damage S Kinsella, CA Evandy, K Cooper, L Iovino, PC DeRoos, KS Hopwo, ... Cell reports 37 (1), 2021 | 7 | 2021 |
| Predictors of response to axicabtagene‐ciloleucel CAR T cells in aggressive B cell lymphomas: A real‐world study L Iovino, QV Wu, J Voutsinas, L Panaite, E Mullane, RC Lynch, C Ujjani, ... Journal of cellular and molecular medicine 26 (24), 5976-5983, 2022 | 6 | 2022 |
| Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review E Milosevic, A Babic, L Iovino, M Markovic, M Grce, H Greinix Frontiers in Immunology 13, 1033263, 2022 | 6 | 2022 |
| Clinical use of an immune monitoring panel in liver transplant recipients: A prospective, observational study L Iovino, R Taddei, ML Bindi, R Morganti, D Ghinolfi, M Petrini, ... Transplant Immunology 52, 45-52, 2019 | 6 | 2019 |
| The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: an Italian … S Galimberti, E Ciabatti, G Ercolano, S Grassi, F Guerrini, N Cecconi, ... Frontiers in Pharmacology 8, 413, 2017 | 6 | 2017 |
| Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms E Benedetti, R Tavarozzi, R Morganti, B Bruno, E Bramanti, C Baratè, ... Journal of clinical medicine 9 (7), 2149, 2020 | 5 | 2020 |
| The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients S Salehzadeh, F Guerrini, U Pizzano, S Grassi, E Ciabatti, L Iovino, ... Cancer Cell International 19, 1-15, 2019 | 5 | 2019 |
